Cargando…

Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer

Starting in 2004, the standard regimen for treatment of Buruli ulcer (BU) recommended by the World Health Organization has been daily treatment for eight weeks with rifampin (RIF) and streptomycin. Based on recent clinical trials, treatment with an all-oral regimen of RIF and clarithromycin (CLR) ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Converse, Paul J., Almeida, Deepak V., Tasneen, Rokeya, Saini, Vikram, Tyagi, Sandeep, Ammerman, Nicole C., Li, Si-Yang, Anders, Nicole M., Rudek, Michelle A., Grosset, Jacques H., Nuermberger, Eric L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107292/ https://www.ncbi.nlm.nih.gov/pubmed/30102705 http://dx.doi.org/10.1371/journal.pntd.0006728

Ejemplares similares

Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
por: Converse, Paul J., et al.
Publicado: (2015)

BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse
por: Converse, Paul J., et al.
Publicado: (2011)

Bactericidal Activity Does Not Predict Sterilizing Activity: The Case of Rifapentine in the Murine Model of Mycobacterium ulcerans Disease
por: Almeida, Deepak V., et al.
Publicado: (2013)

Accelerated Detection of Mycolactone Production and Response to Antibiotic Treatment in a Mouse Model of Mycobacterium ulcerans Disease
por: Converse, Paul J., et al.
Publicado: (2014)

Activities of Rifampin, Rifapentine and Clarithromycin Alone and in Combination against Mycobacterium ulcerans Disease in Mice
por: Almeida, Deepak, et al.
Publicado: (2011)

Rapid, Serial, Non-invasive Assessment of Drug Efficacy in Mice with Autoluminescent Mycobacterium ulcerans Infection
por: Zhang, Tianyu, et al.
Publicado: (2013)

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer
por: Doig, Kenneth D, et al.
Publicado: (2012)

The Incubation Period of Buruli Ulcer (Mycobacterium ulcerans Infection)
por: Trubiano, Jason A., et al.
Publicado: (2013)

Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)
por: Yotsu, Rie R, et al.
Publicado: (2018)

Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
por: Li, Si-Yang, et al.
Publicado: (2017)

Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies
por: Zhang, Nan, et al.
Publicado: (2020)

Spontaneous Clearance of Mycobacterium ulcerans in a Case of Buruli Ulcer
por: Gordon, Claire L., et al.
Publicado: (2011)

Aquatic Insects and Mycobacterium ulcerans: An Association Relevant to Buruli Ulcer Control?
por: Silva, Manuel T, et al.
Publicado: (2007)

Risk of Buruli Ulcer and Detection of Mycobacterium ulcerans in Mosquitoes in Southeastern Australia
por: Lavender, Caroline J., et al.
Publicado: (2011)

Detection of Mycobacterium ulcerans in the Environment Predicts Prevalence of Buruli Ulcer in Benin
por: Williamson, Heather R., et al.
Publicado: (2012)

Linking the Mycobacterium ulcerans environment to Buruli ulcer disease: Progress and challenges
por: Dhungel, Laxmi, et al.
Publicado: (2021)

Targeting the Mycobacterium ulcerans cytochrome bc(1):aa(3) for the treatment of Buruli ulcer
por: Scherr, Nicole, et al.
Publicado: (2018)

Susceptibility to Mycobacterium ulcerans Disease (Buruli ulcer) Is Associated with IFNG and iNOS Gene Polymorphisms
por: Bibert, Stéphanie, et al.
Publicado: (2017)

Microbiological, Histological, Immunological, and Toxin Response to Antibiotic Treatment in the Mouse Model of Mycobacterium ulcerans Disease
por: Sarfo, Fred Stephen, et al.
Publicado: (2013)

Impact of Mycobacterium ulcerans Biofilm on Transmissibility to Ecological Niches and Buruli Ulcer Pathogenesis
por: Marsollier, Laurent, et al.
Publicado: (2007)

Mycobacterium ulcerans in Mosquitoes Captured during Outbreak of Buruli Ulcer, Southeastern Australia
por: Johnson, Paul D.R., et al.
Publicado: (2007)

Mycobacterium ulcerans Persistence at a Village Water Source of Buruli Ulcer Patients
por: Bratschi, Martin W., et al.
Publicado: (2014)

A protocol for culturing environmental strains of the Buruli ulcer agent, Mycobacterium ulcerans
por: Zingue, Dezemon, et al.
Publicado: (2018)

Seasonal Pattern of Mycobacterium ulcerans, the Causative Agent of Buruli Ulcer, in the Environment in Ghana
por: Aboagye, Samuel Yaw, et al.
Publicado: (2017)

Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis
por: Ruf, Marie-Thérèse, et al.
Publicado: (2016)

Understanding the transmission of Mycobacterium ulcerans: A step towards controlling Buruli ulcer
por: Muleta, Anthony J., et al.
Publicado: (2021)

Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against Mycobacterium ulcerans
por: Dominguez, Juan, et al.
Publicado: (2023)

Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model
por: Bolz, Miriam, et al.
Publicado: (2016)

Distribution of Mycobacterium ulcerans in Buruli Ulcer Endemic and Non-Endemic Aquatic Sites in Ghana
por: Williamson, Heather R., et al.
Publicado: (2008)

Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer disease.
por: Dobos, K M, et al.
Publicado: (2000)

Mycobacterium ulcerans Disease (Buruli Ulcer) in Rural Hospital, Southern Benin, 1997–2001
por: Debacker, Martine, et al.
Publicado: (2004)

Fish and amphibians as potential reservoirs of Mycobacterium ulcerans, the causative agent of Buruli ulcer disease
por: Willson, Sarah J., et al.
Publicado: (2013)

Environmental transmission of Mycobacterium ulcerans drives dynamics of Buruli ulcer in endemic regions of Cameroon
por: Garchitorena, Andrés, et al.
Publicado: (2015)

Mycobacterium ulcerans Population Genomics To Inform on the Spread of Buruli Ulcer across Central Africa
por: Vandelannoote, Koen, et al.
Publicado: (2019)

Decrease in Mycobacterium ulcerans disease (Buruli ulcer) in the Lalo District of Bénin (West Africa)
por: Anagonou, Esaï Gimatal, et al.
Publicado: (2019)

Evidences of the Low Implication of Mosquitoes in the Transmission of Mycobacterium ulcerans, the Causative Agent of Buruli Ulcer
por: Djouaka, Rousseau, et al.
Publicado: (2017)

PPE Barcoding Identifies Biclonal Mycobacterium ulcerans Buruli Ulcer, Côte d’Ivoire
por: Tchan, B. G. O., et al.
Publicado: (2023)

Locally Confined Clonal Complexes of Mycobacterium ulcerans in Two Buruli Ulcer Endemic Regions of Cameroon
por: Bolz, Miriam, et al.
Publicado: (2015)

Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease
por: Sarfo, Fred Stephen, et al.
Publicado: (2015)

Mycobacterium ulcerans DNA in Bandicoot Excreta in Buruli Ulcer–Endemic Area, Northern Queensland, Australia
por: Röltgen, Katharina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jo103mva5i3r7sr1c79uvk8pdv